In Vitro Fertilization Market: Growth Trends, Drivers, and Regional Outlook
The global in vitro fertilization (IVF) market has emerged as one of the fastest-growing segments within assisted reproductive technology (ART), driven by rising infertility rates, delayed pregnancies, and increasing awareness of fertility treatment options worldwide. The global in vitro fertilization market size was valued at USD 28.97 billion in 2025 and is projected to grow from USD 30.99 billion in 2026 to USD 53.25 billion by 2034, exhibiting a CAGR of 7.00% during the forecast period, according to Fortune Business Insight. Europe dominated the IVF market with a share of 44.82% in 2025, according to Fortune Business Insight.
IVF is one of the most widely adopted assisted reproductive technologies, combining medicines and surgical procedures to support embryo development and implantation in couples facing infertility. The process involves retrieving eggs and sperm and combining them in a laboratory setting before transferring the resulting embryo into the uterus. The growing adoption of IVF has contributed to roughly half a million babies being born every year through IVF or related assisted reproductive techniques, a trend expected to continue boosting the market during the forecast period.
Key Market Drivers
Delayed Pregnancies Fueling Demand
One of the most significant drivers of the IVF market is the global trend toward delayed pregnancies. Fertility in women tends to decline after the age of 32 and drops sharply by age 40. Factors such as late marriages, career prioritization, and financial instability have pushed the median age of first-time pregnancy higher in many countries, leading to increased infertility rates and, in turn, higher demand for IVF treatment. Studies estimate that the average global fertility rate has declined by 2.5%, with delayed pregnancies cited as a major contributing factor.
Rising Prevalence of Infertility
The increasing prevalence of infertility across countries such as China, the U.S., the UK, and Japan continues to fuel demand for IVF treatment, according to Fortune Business Insight. Data from the National Survey of Family Growth indicated that around 6.7% of women in the U.S. aged 15 to 44 experienced infertility, while male infertility has also become a growing concern globally, with men solely responsible for a significant share of infertility cases among couples. Lifestyle factors such as sedentary habits, rising stress levels, and obesity further compound this trend, pushing more couples toward fertility treatments. Supportive government reimbursement policies in several countries are also expected to encourage greater adoption of IVF procedures.
Market Segmentation
The IVF market is segmented by type, procedure, and end user. By type, the market includes conventional IVF and IVF with ICSI (intracytoplasmic sperm injection), with the IVF-ICSI segment holding a dominant position due to its effectiveness in addressing male infertility. Conventional IVF, meanwhile, continues to grow steadily as it involves comparatively lower risk and offers similar success rates to ICSI in cases where female infertility is the primary concern.
By procedure, the market is divided into fresh non-donor, frozen non-donor, fresh donor, and frozen donor categories. Fresh non-donor procedures have historically demonstrated higher live birth rates, while frozen non-donor procedures remain popular due to their lower cost relative to fresh-cycle treatments. Fresh and frozen donor segments are expected to grow at a comparatively moderate pace, largely due to strict regulatory frameworks governing egg and sperm donation in many countries.
By end user, fertility clinics dominate the market, benefiting from specialized staff and a growing number of registered clinics across both developed and emerging economies. Hospitals, on the other hand, account for a comparatively smaller share, constrained by fewer patient visits for infertility treatment and limited in-house expertise.
Regional Analysis
Europe remains the dominant region in the global IVF market, generating a revenue of USD 7.57 billion in 2026, according to Fortune Business Insight. The region's leadership is attributed to high infertility prevalence and strong treatment success rates, with countries like Spain and Denmark recognized as particularly active in IVF adoption.
North America is expected to register steady growth, tempered somewhat by the high cost of treatment, which has pushed some patients to seek more affordable IVF options abroad.
Asia Pacific is projected to post the fastest growth rate among all regions, supported by rising awareness of infertility, increasing medical tourism, and a growing number of registered fertility clinics across countries including Japan, China, and India.
Industry Landscape
Prominent players in the IVF market include Monash IVF, Boston IVF, and Pelargos IVF, known for comprehensive treatment backed by specialized medical staff. Other notable providers such as Bloom IVF Centre and Bangkok IVF Center have carved a niche by offering more affordable treatment options, contributing to rising medical tourism. Additional players in the competitive landscape include Ovation Fertility, Shady Grove Fertility, and Group Ambroise Paré Clinic.
Conclusion
The IVF market is poised for sustained growth over the coming years, propelled by rising infertility rates, delayed family planning trends, and continuous advancements in fertility treatment technologies such as ICSI. While high treatment costs and associated health risks remain challenges, expanding clinic networks, improving success rates, and supportive reimbursement policies in several regions are expected to keep the market on a strong growth trajectory through 2034.
What's Driving Japan's Market? Discover the Latest "In Vitro Fertilization Market" Insights
https://www.fortunebusinessinsights.com/jp/体外受精（ivf）市場-102189